Vupanorsen

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameVupanorsen
Drug Alias NameIONIS-ANGPTL3RxISIS-703802PF-07285557
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAngiopoietin like 3 inhibitors
TargetsAngiopoietin like 3
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaHypertriglyceridemiaHyperlipoproteinemias +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesIonis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Manufacturing Belgium NvPfizer Investment Co Ltd
Inactive CompaniesIonis Pharmaceuticals IncAkcea Therapeutics Inc
Active IndicationsHypertriglyceridemiaHyperlipoproteinemiasHyperlipidemias +[5] 
Inactive IndicationsHomozygous familial hypercholesterolemiaDiabetes Mellitus, Type 2Hyperlipoproteinemia Type II +[5] 

Other Information

ATC CodeN/A
Related LinksN/A